• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌。

Adenocarcinoma of the urinary bladder.

机构信息

Department of Pathology, University of Pittsburgh Medical Center, Pennsylvania 15261, USA.

出版信息

Arch Pathol Lab Med. 2011 Dec;135(12):1601-5. doi: 10.5858/arpa.2009-0713-RS.

DOI:10.5858/arpa.2009-0713-RS
PMID:22129192
Abstract

Primary adenocarcinoma of urinary bladder is an uncommon neoplasm and is a source of diagnostic confusion with adenocarcinomas arising in adjacent organs, especially colon. These tumors show varied histologic picture and degree of differentiation. Clinical association with bladder exstrophy and schistosomiasis has been well documented. Primary bladder adenocarcinomas have overlapping histologic and immunohistochemical features with adenocarcinomas arising from other primary sites and the suggested immunohistochemical panel includes cytokeratins 7 and 20, 34βE12, thrombomodulin, CDX2, and β-catenin. Clinical, imaging, histologic, and immunohistochemical correlation should be done while rendering this diagnosis, as prognosis and therapeutic options for primary versus metastatic adenocarcinoma vary widely.

摘要

原发性膀胱腺癌是一种罕见的肿瘤,与邻近器官(尤其是结肠)的腺癌相比,其在诊断上容易混淆。这些肿瘤具有不同的组织学表现和分化程度。文献已经充分记载了其与膀胱外翻和血吸虫病的临床关联。原发性膀胱腺癌与来自其他原发部位的腺癌具有重叠的组织学和免疫组织化学特征,建议的免疫组织化学标志物包括细胞角蛋白 7 和 20、34βE12、血栓调节蛋白、CDX2 和β-连环蛋白。在做出这一诊断时,应进行临床、影像学、组织学和免疫组织化学相关性分析,因为原发性与转移性腺癌的预后和治疗选择差异很大。

相似文献

1
Adenocarcinoma of the urinary bladder.膀胱癌。
Arch Pathol Lab Med. 2011 Dec;135(12):1601-5. doi: 10.5858/arpa.2009-0713-RS.
2
Histologic variants of infiltrating urothelial carcinoma.浸润性尿路上皮癌的组织学变异型。
Arch Pathol Lab Med. 2008 Oct;132(10):1546-7author reply 1547. doi: 10.5858/2008-132-1546c-HVOIUC.
3
Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.免疫组织化学分析脐尿管上皮性肿瘤的形态谱:诊断意义和陷阱。
Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.
4
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.免疫组化在膀胱原发性与继发性肠道腺癌鉴别诊断中的应用
Appl Immunohistochem Mol Morphol. 2005 Dec;13(4):358-62. doi: 10.1097/01.pai.0000136552.44045.0f.
5
Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.原发性前列腺黏液分泌性尿路上皮型腺癌:15例报告
Am J Surg Pathol. 2007 Sep;31(9):1323-9. doi: 10.1097/PAS.0b013e31802ff7c4.
6
CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.CDX2、细胞角蛋白7和20在直肠腺癌中的免疫反应性。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):196-201. doi: 10.1097/PAI.0b013e31819268f2.
7
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.原发性膀胱腺癌与转移性结直肠腺癌:持续存在的诊断挑战。
Diagn Pathol. 2012 Nov 2;7:151. doi: 10.1186/1746-1596-7-151.
8
[Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum].[免疫组织化学在腹膜腺癌转移灶中的鉴别诊断重要性]
Akush Ginekol (Sofiia). 2009;48(5):20-2.
9
Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.CDX2、绒毛蛋白和α-甲基酰基辅酶A消旋酶免疫染色在膀胱原发性腺癌与继发性结直肠癌鉴别诊断中的价值
Mod Pathol. 2005 Sep;18(9):1217-22. doi: 10.1038/modpathol.3800407.
10
Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain.组织特异性转录因子甲状腺转录因子1和Cdx2在确定脑转移性腺癌原发部位中的作用。
Arch Pathol Lab Med. 2007 Nov;131(11):1686-90. doi: 10.5858/2007-131-1686-UOTTFT.

引用本文的文献

1
Urinary bladder collision tumors: A case report and literature review.膀胱碰撞瘤:一例报告及文献综述
Med Int (Lond). 2025 Mar 7;5(3):26. doi: 10.3892/mi.2025.225. eCollection 2025 May-Jun.
2
Comprehensive genomic profiling of primary bladder mucinous adenocarcinoma, a rare genitourinary cancer: A case report.原发性膀胱黏液腺癌的综合基因组分析,一种罕见的泌尿生殖系统癌症:病例报告
Urol Case Rep. 2024 Nov 22;58:102892. doi: 10.1016/j.eucr.2024.102892. eCollection 2025 Jan.
3
Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report.
膀胱黏液性腺癌的诊断挑战:一例报告。
Pan Afr Med J. 2022 Jul 20;42:221. doi: 10.11604/pamj.2022.42.221.35032. eCollection 2022.
4
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy.一种预测膀胱部分切除术后肌层浸润性膀胱癌患者癌症特异性生存的新型列线图和风险分类系统。
J Oncol. 2022 Mar 1;2022:2665711. doi: 10.1155/2022/2665711. eCollection 2022.
5
Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity.苗勒管腺肉瘤:单中心59例这种罕见实体瘤的经验
Cureus. 2021 Feb 15;13(2):e13360. doi: 10.7759/cureus.13360.
6
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.肺肝样腺癌:监测、流行病学和最终结果(SEER)数据库分析
Open Med (Wars). 2021 Jan 22;16(1):169-174. doi: 10.1515/med-2021-0215. eCollection 2021.
7
Mucinous adenocarcinoma of renal pelvis in a young male: a diagnostic challenge.肾盂黏液腺癌在年轻男性中的表现:诊断难点。
Ger Med Sci. 2020 Nov 25;18:Doc11. doi: 10.3205/000287. eCollection 2020.
8
Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial Cystectomy: A Case Report and Review of the Literature.膀胱部分切除术治疗原发性膀胱印戒细胞腺癌:一例报告并文献复习
Case Rep Urol. 2017;2017:6829692. doi: 10.1155/2017/6829692. Epub 2017 Dec 11.
9
Bladder Adenocarcinoma: A Persisting Diagnostic Dilemma.膀胱腺癌:持续存在的诊断难题
J Clin Diagn Res. 2017 Mar;11(3):ER01-ER04. doi: 10.7860/JCDR/2017/24590.9536. Epub 2017 Mar 1.
10
Primary Mucinous Adenocarcinoma of the Urinary Bladder with Signet-Ring Cells: Description of an Uncommon Case and Critical Points in Its Management.伴有印戒细胞的膀胱原发性黏液腺癌:1例罕见病例描述及其治疗要点
Case Rep Urol. 2016;2016:6080859. doi: 10.1155/2016/6080859. Epub 2016 Dec 18.